/Companies

ALZpath

Carlsbad, US · Delaware corporation · 10 employees on LinkedIn

Find your way into ALZpath

Sign up to see every warm intro you have to ALZpath

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ALZpath team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Alzpath develops diagnostic tools for early and accurate detection of Alzheimer's disease. The company serves clinicians and patients seeking improved diagnostic accuracy and accessibility across the care pathway.

Founders & leadership

MB
Michael BanvilleNamed on SEC filing

Board

IR
Irit RappleyBoard director
JS
Jerre SteadBoard director
HJ
Harry JohnsBoard director
JCJohn Courtney
John CourtneyBoard MemberOperating Partner at InTandem Capital Partners
JH
John HensingBoard director
SB
Samantha Budd HaeberleinBoard director

Reported raises · per SEC filings

Form D private placements

$8.4M disclosed across 1 round · 2026

▶$8.4MraisedJul 2026 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BanvilleExecutive Officer, Promoter
  • Jerre SteadDirector
  • Harry JohnsDirector
  • John CourtneyDirector
  • John HensingDirector
  • Irit RappleyDirector
  • Samantha Budd HaeberleinDirector
Offering amount
$10.4M
Amount sold
$8.4M
Finders' fees
$125K
Placement agents
AEG Capital, LLC
First sale
Jul 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Companies working in the same space as ALZpath.

In the news

Frequently asked questions

What does ALZpath do?
Alzpath develops diagnostic tools for early and accurate detection of Alzheimer's disease. The company serves clinicians and patients seeking improved diagnostic accuracy and accessibility across the care pathway.
How much funding has ALZpath raised?
ALZpath has disclosed $8.4M raised across 1 round.
Where is ALZpath headquartered?
ALZpath is headquartered in Carlsbad, US.